J. Taranger

发表

Pubertal growth and maturity pattern in early and late maturers. A prospective longitudinal study of Swedish urban children.

U. Hägg, J. Taranger, 1992, Swedish dental journal.

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

R. Schneerson, J. Robbins, B. Claesson, 1990, The Journal of pediatrics.

The somatic development of children in a swedish urban community.

J. Taranger, P. Karlberg, 1976, Acta paediatrica Scandinavica. Supplement.

Somatic Pubertal Development

J. Taranger, H. Lichtenstein, I. Engström, 1976 .

A new method for the assessment of skeletal maturity ‐the MAT ‐ method (mean appearance time of bone stages)

J. Taranger, I. Claesson, P. Karlberg, 1976, Acta paediatrica Scandinavica. Supplement.

Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.

A. Strandell, J. Taranger, B. Christenson, 1987, British medical journal.

Sensitivity to sensitins and tuberculin in Swedish children. II. A study of preschool children.

J. Taranger, L. Larsson, M. Bentzon, 1991, Tubercle.

Monocomponent Pertussis Toxoid Vaccine Immunologic and Epidemiologic Experience of Vaccination With a

R. Schneerson, J. Robbins, J. Taranger, 2013 .

Determination of pertactin IgG antibodies for the diagnosis of pertussis.

J. Taranger, B. Trollfors, T. Lagergård, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

R. Schneerson, J. Robbins, J. Taranger, 2001, Pediatrics.

Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

J. Taranger, V. Sundh, B. Trollfors, 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.

R. Schneerson, J. Robbins, D. Bryla, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.

J. Robbins, D. Bryla, J. Taranger, 1997, The Journal of pediatrics.

Physical growth from birth to 16 years and longitudinal outcome of the study during the same age period

J. Karlberg, J. Taranger, P. Karlberg, 1976, Acta paediatrica Scandinavica. Supplement.

Unequal mitotic sister chromatid exchange and different length of Y chromosomes

J. Taranger, J. Wahlström, M. Kyllerman, 1985, Human Genetics.

The Relationship Between Dental and Somatic Development in Puberty

U. Hägg, J. Taranger, 1984 .

[A method for assessing sex characteristics during puberty].

J. Taranger, P. Karlberg, H. Lichtenstein, 1973, Lakartidningen.

Evaluation of PCR for Diagnosis of Bordetella pertussis and Bordetella parapertussisInfections

C. Welinder-Olsson, J. Taranger, B. Trollfors, 1998, Journal of Clinical Microbiology.

[Diagnosis of tuberculous pleurisy. Importance of needle-biopsy of the pleura and culture of the fragment (computer study)].

J. Charpin, J. Taranger, A. Arnaud, 1968, Revue de tuberculose et de pneumologie.

A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned

R. Schneerson, J. Robbins, J. Taranger, 1996, The Lancet.

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.

R. Schneerson, J. Robbins, D. Bryla, 2000, The Journal of infectious diseases.

Immunity to pertussis. Not all virulence factors are protective antigens.

R. Schneerson, J. Robbins, D. Bryla, 1998, Advances in experimental medicine and biology.

Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.

J. Taranger, B. Trollfors, T. Lagergård, 1995, The Pediatric infectious disease journal.

Parapertussis infection followed by pertussis infection

J. Taranger, B. Trollfors, T. Lagergård, 1994, The Lancet.

Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine

M. Pittman, R. Schneerson, J. Robbins, 1993, The Pediatric infectious disease journal.

Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children.

R. Schneerson, J. Robbins, I. Krantz, 1990, The Journal of pediatrics.

History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.

J. Taranger, B. Trollfors, G. Zackrisson, 1990, The Journal of pediatrics.

Vaccination of infants with a four-dose and a three-dose vaccination schedule.

J. Taranger, V. Sundh, B. Trollfors, 1999, Vaccine.

REDUCED IMMUNOGENICITY OF DIPHTHERIA AND TETANUS TOXOIDS WHEN COMBINED WITH PERTUSSIS TOXOID

J. Taranger, V. Sundh, B. Trollfors, 2005, The Pediatric infectious disease journal.

Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.

P. Anderson, R. Schneerson, J. Robbins, 1996, The Pediatric infectious disease journal.

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

R. Schneerson, J. Robbins, D. Bryla, 1988, The Journal of pediatrics.

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.

R. Schneerson, J. Robbins, D. Bryla, 1989, The Journal of pediatrics.

Haemophilus influenzae meningitis in Sweden 1981-1983.

B. Claesson, J. Taranger, B. Trollfors, 1987, Archives of disease in childhood.

Comparison of a toxin neutralization assay and ELISA for determination of pertussis toxin antibodies

J. Taranger, B. Trollfors, J. Isacson, 1997 .

Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells.

I. Krantz, N. Sigurs, J. Taranger, 1988, The Journal of infectious diseases.

Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay

P. Larsson, I. Krantz, N. Sigurs, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.

J. Taranger, B. Trollfors, G. Hedvall, 1995, Scandinavian journal of infectious diseases.

Toxoid vaccine for pertussis

R. Schneerson, J. Robbins, J. Taranger, 1997, The Lancet.

Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts.

I. Krantz, J. Taranger, B. Trollfors, 1989, International journal of epidemiology.

Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B.parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis

R. Schneerson, J. Robbins, J. Taranger, 2001, Clinical Diagnostic Laboratory Immunology.

How common is whooping cough in a nonvaccinating country?

J. Taranger, B. Trollfors, T. Lagergård, 1993, The Pediatric infectious disease journal.

Immunization of children with pertussis toxoid decreases spread of pertussis within the family.

R. Schneerson, J. Robbins, D. Bryla, 1998, The Pediatric infectious disease journal.

Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose

J. Taranger, V. Sundh, B. Trollfors, 2005, European Journal of Pediatrics.

Towards better pertussis vaccines.

J. Taranger, B. Trollfors, 1997, Annals of medicine.

Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.

J. Robbins, H. Cicirello, J. Taranger, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria

B. Claesson, J. Taranger, B. Trollfors, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis.

J. Taranger, B. Trollfors, T. Lagergård, 1992, The Journal of pediatrics.

Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.

H. Käyhty, H. Cicirello, J. Taranger, 2001, Vaccine.

Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.

J. Taranger, B. Trollfors, N. Knutsson, 1997, Developments in biological standardization.

Protection against pertussis with a monocomponent pertussis toxoid vaccine.

J. Robbins, J. Taranger, B. Trollfors, 1999, Biologicals : journal of the International Association of Biological Standardization.

On observer errors in pertussis vaccine studies.

J. Taranger, B. Trollfors, 1997, The Pediatric infectious disease journal.

Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content

L. Hanson, J. Taranger, B. Carlsson, 1993, Acta paediatrica.

VACCINATION PROGRAMME FOR ERADICATION OF MEASLES, MUMPS, AND RUBELLA

J. Taranger, 1982, The Lancet.

Skeletal development from birth to 7 years

J. Taranger, I. Claesson, P. Karlberg, 1976 .

[The low number of reported adverse effects after vaccination against measles, mumps, rubella].

B. Wiholm, J. Taranger, 1987, Lakartidningen.

Skeletal stages of the hand and wrist as indicators of the pubertal growth spurt.

U. Hägg, J. Taranger, J. Taranger, 1980, Acta odontologica Scandinavica.

Maturation indicators and the pubertal growth spurt.

U Hägg, U. Hägg, J. Taranger, 1982, American journal of orthodontics.

Hepatitis B carriers in Sweden--effects of immigration.

G. Norkrans, M. Lindh, J. Taranger, 1993, Scandinavian journal of infectious diseases.

Dental Development from Birth to 16 Years

J. Taranger, H. Lichtenstein, I. Svennberg‐Redegren, 1976 .

Environmental contamination leading to false-positive polymerase chain reaction for pertussis.

J. Taranger, B. Trollfors, L. Lind, 1994, The Pediatric infectious disease journal.

3. GROWTH CHARTS FOR HEIGHT, WEIGHT AND HEAD CIRCUMFERENCE

J. Taranger, P. Karlberg, I. Klackenberg-Larsson, 1973 .

[Growth diagrams for height, weight and head circumference from birth to the age of 18 years].

J. Taranger, P. Karlberg, I. Klackenberg-Larsson, 1973, Läkartidningen.

Evaluation of biological maturation by means of maturity criteria

J. Taranger, 1976, Acta paediatrica Scandinavica. Supplement.

The timing and duration of adolescent growth.

U. Hägg, J. Taranger, 1980, Acta odontologica Scandinavica.

Long‐term Treatment with Corticosteroids/ACTH in Asthmatic Children

J. Karlberg, J. Taranger, B. Bruning, 1986, Acta paediatrica Scandinavica.

Increasing the uptake of rubella immunisation.

J. Taranger, 1985, British medical journal.

Scandinavian model for eliminating measles, mumps, and rubella.

J. Taranger, E. Rabo, 1984, British medical journal.

Height and height velocity in early, average and late maturers followed to the age of 25: a prospective longitudinal study of Swedish urban children from birth to adulthood.

U. Hägg, J. Taranger, 1991, Annals of human biology.

Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age

L. Hagberg, M. Wahl, J. Taranger, 1995, The Pediatric infectious disease journal.

Intrauterine varicella: a report of two cases associated with hyper-A-immunoglobulinemia.

O. Strannegard, J. Taranger, J. Blomberg, 1981, Scandinavian journal of infectious diseases.

Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

R. Schneerson, J. Robbins, D. Bryla, 1991, The Pediatric infectious disease journal.

Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren.

J. Taranger, B. Christenson, M. Böttiger, 1985, Vaccine.

Screening for congenital hypothyroidism in the newborn.

L. Victorin, J. Taranger, I. Claesson, 1973, Lancet.

A placebo-controlled trial of a pertussis-toxoid vaccine.

W. Blackwelder, J. Robbins, J. Taranger, 1995, The New England journal of medicine.

Timing of tooth emergence. A prospective longitudinal study of Swedish urban children from birth to 18 years.

U. Hägg, J. Taranger, 1986, Swedish dental journal.

Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants.

J. Robbins, D. Bryla, J. Taranger, 1997, The Pediatric infectious disease journal.

Dental emergence stages and the pubertal growth spurt.

U. Hägg, J. Taranger, 1981, Acta odontologica Scandinavica.

Menarche and voice change as indicators of the pubertal growth spurt.

U Hägg, U. Hägg, J. Taranger, 1980, Acta odontologica Scandinavica.

Dental development assessed by tooth counts and its correlation to somatic development during puberty.

U. Hägg, J. Taranger, 1984, European journal of orthodontics.

Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.

M. L. Ciofi Degli Atti, A. Tozzi, M. Préziosi, 1997, Developments in biological standardization.

Dental development, dental age and tooth counts.

U. Hägg, J. Taranger, 1985, The Angle orthodontist.

VI. Somatic pubertal development.

J. Taranger, H. Lichtenstein, I. Engström, 1976, Acta paediatrica Scandinavica. Supplement.

Immunity to Pertussis

R. Schneerson, J. Robbins, D. Bryla, 1998 .

Elimination of Childhood Diseases: Possible Influence on the Incidence of Multiple Sclerosis Soon Detectable

O. Andersen, J. Taranger, L. Johansson, 2002, Neuroepidemiology.

Graphic analysis of biological maturation by means of maturograms

J. Taranger, P. Karlberg, 1976, Acta paediatrica Scandinavica. Supplement.